Rethinking asthma

Hot topics
Chairs: T. Geiser (Bern, Switzerland), D. Stolz (Basel, Switzerland)
Aims: To give insights into the management strategy and new treatments across the spectrum of asthma; to present evolution in our understanding of asthma phenotypes and endotypes and their relevance in daily clinical practice.

Refining asthma treatment for mild asthma R. Buhl (Mainz, Germany)
Identifying patients with severe asthma that will be benefit from biological therapy C. Porsbjerg (Copenhagen, Denmark)
What is it about responders and non-responders in asthma? From biology to physiology and treatment M. Idzko (Wien, Austria)
Is severe neutrophilic asthma a separate entity ?: Pro A. Maitland-van der Zee (Amsterdam, Netherlands)
Is severe neutrophilic asthma a separate entity?:Con P. Nair (Hamilton (ON), Canada)